Mass General Hospital, Est. 1811

Depression Clinical
and Research Program

  • Home
  • Clinical Care
  • Depression Information
    • About Depression
    • Alternate Treatments
      for Depression
    • Psychiatry in
      Primary Care
    • menu bottom image
  • Publications
    • Alternative Treatments for Depression
    • Treatment Resistant Depression
    • Major Depression and Other Disorders
    • Medication Side Effects
    • Minor Depression
    • Treatments for Depression
    • Psychotic Depression
    • Hormone/Biological/Genetic Research on Depression
    • Books
    • menu bottom image
  • Current Studies
    • Dual Diagnoses Studies
    • Studies for depressed patients not taking any antidepressants
    • Studies for depressed patients currently taking antidepressants
    • Non-treatment Studies
    • Studies for Smoking Cessation & Relapse Prevention
    • Other Studies
    • Psychotherapy Studies
    • menu bottom image
  • Links
  • Staff
    • Director
    • Associate Directors
    • Psychiatrists
    • Psychologists
    • Administrative Staff
    • Program Coordinator
    • Research Coordinators
    • Previous Staff
    • menu bottom image
  • Funding
    • The Goldstein Fund
    • The Judith Brown Caro Fund
    • Donations
    • menu bottom image
  • Contact
  • All Current Studies
  • Dual Diagnoses Studies
  • Studies for depressed patients not taking any antidepressants
  • Studies for depressed patients currently taking antidepressants
  • Non-treatment studies
  • Studies for Smoking Cessation & Relapse Prevention
  • Other Studies
  • Psychotherapy Studies
    • QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
    • Neural Correlates of Psychodynamic Psychotherapy for Depression
    • Psychosocial treatment of Depressive disorders in Parkinson's Disease
    • Stress Reduction Intervention for Depressed Minority Patients

Psychosocial treatment of Depressive disorders in Parkinson's Disease

We are looking at non-motor symptoms of Parkinson’s disease, such as symptoms of depression and anxiety, and how to best treat these symptoms with a form of talk therapy called cognitive behavioral therapy (CBT). If eligible for the study, you will participate in CBT, and you will either start CBT right away, or you may be assigned to start treatment in 12 weeks. Your participation in this study will take approximately 13 weeks or approximately 25 weeks depending on your treatment assignment. All participants will receive CBT treatment at some point in the study.

If you are interested and would like more information, please contact Amy Farabaugh, PhD at 617-726-1629 (afarabaugh@partners.org) or Carrie Brintz at 617-726-5805 (cbrintz@partners.org)


We initiate new studies regularly, so please contact us for additional information.

© 2008 The Depression Clinical and Research Program at Massachusetts General Hospital
50 Staniford Street, 4th Floor | Boston, MA 02114 | 1-877-552-5837

Directions